The Impact of State Dementia Training Requirements for Nursing Homes on Antipsychotic Medication Use

被引:1
|
作者
Shier, Victoria [1 ,5 ]
Bae-Shaaw, Yuna H. [2 ]
Sood, Neeraj [1 ]
Lekovitch, Cara [3 ]
Chew, Felicia [4 ]
Leland, Natalie E. [3 ]
机构
[1] Univ Southern Calif, Sol Price Sch Publ Policy, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA 90007 USA
[2] Univ Calif Los Angeles, USC Mann Sch Pharm & Pharmaceut Sci, Titus Family Dept Clin Pharm, Los Angeles, CA USA
[3] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, Pittsburgh, PA USA
[4] Thomas Jefferson Univ, Dept Occupat Therapy, Pittsburgh, PA USA
[5] 635 Downey Way, Los Angeles, CA 90089 USA
关键词
Regulations; staff; antipsychotic medications; LONG-TERM-CARE; PSYCHOLOGICAL SYMPTOMS; RISK; RESIDENTS; BURDEN; HYPERLIPIDEMIA; ASSOCIATION; RISPERIDONE; OLANZAPINE; CLOZAPINE;
D O I
10.1016/j.jamda.2023.10.017
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: Nursing home (NH) staff often report not having adequate dementia-specific knowledge to effectively care for these residents. Between 2011 and 2019, 9 states in the United States implemented dementia training requirements for NH staff. This study evaluated whether the state-mandated dementia training for NH staff was associated with improving resident outcomes. Design: Compared trends in antipsychotic medication before and after implementation of state training requirements to trends in states without requirements. Setting and Participants: NHs. Methods: Data from Care Compare for NHs and LTCFocus were linked to state policy data. We excluded 14 states that had implemented training requirements before the start of the study period in 2011. We estimated difference-in-differences models that compared trends in antipsychotic medication use before and after implementation of training requirements in states that have newly implemented requirements to trends in states without requirements. We also investigated whether the impact of training was larger in states with more stringent training requirements (eg, specifying a minimum number of training hours) and in NHs with a special care unit for dementia and examined similar analyses for restraint use and falls. Results: We found that training requirements were associated with a 0.59-percentage point reduction (95% CI -0.91 to -0.27) in antipsychotics use. Effects were larger in NHs with a special care unit for dementia and in states that had stricter training requirements. We also found that training requirements were associated with a 0.17-percentage point reduction (95% CI -0.26 to -0.07) in restraint use measure and had no impact on falls. Conclusions and Implications: State requirements for NH staff dementia training were associated with a small, but significant, reduction in the use of antipsychotic medication and physical restraints. (c) 2023 AMDA - The Society for Post-Acute and Long-Term Care Medicine.
引用
收藏
页码:209 / 214.e1
页数:7
相关论文
共 50 条
  • [21] National Partnership to Improve Dementia Care in Nursing Homes Campaign: State and Facility Strategies, Impact, and Antipsychotic Reduction Outcomes
    Crystal, Stephen
    Jarrin, Olga F.
    Rosenthal, Marsha
    Hermida, Richard
    Angell, Beth
    INNOVATION IN AGING, 2020, 4 (03) : 1 - 13
  • [22] A qualitative study investigating training requirements of nurses working with people with dementia in nursing homes
    Smythe, Analisa
    Jenkins, Catharine
    Galant-Miecznikowska, Magdalena
    Bentham, Peter
    Oyebode, Jan
    NURSE EDUCATION TODAY, 2017, 50 : 119 - 123
  • [23] USE OF ANTIPSYCHOTIC MEDICATIONS IN NURSING-HOMES
    DIMANT, J
    CLINICAL RESEARCH, 1986, 34 (02): : A363 - A363
  • [24] Who you are and where you are influences antipsychotic use in people with dementia living in nursing homes
    Rataj, Alison C.
    Alcusky, Matthew
    Baek, Jonggyu
    Lapane, Kate
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 362 - 362
  • [25] Use of psychiatric medication in three Arctic nursing homes: association with dementia and psychiatric symptoms
    Gisladottir, Sigurveig
    Sigurdardottir, Arun K.
    Hjaltadottir, Ingibjorg
    INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH, 2021, 80 (01)
  • [26] Improving Antipsychotic Agent Use in Nursing Homes: Development of an Algorithm for Treating Problem Behaviors in Dementia
    Smith, Marianne
    Schultz, Susan K.
    Seydel, Linda L.
    Reist, Jeffrey
    Kelly, Michael
    Weckman, Michelle
    Gryzlak, Brian
    Carnahan, Ryan
    JOURNAL OF GERONTOLOGICAL NURSING, 2013, 39 (05): : 24 - 37
  • [27] Explained Variation in Antipsychotic Medication Prescribing in Patients Admitted to Nursing Homes
    Huybrechts, Krista
    Rothman, Kenneth J.
    Brookhart, M. Alan
    Silliman, Rebecca
    Crystal, Stephen
    Schneeweiss, Sebastian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S230 - S230
  • [28] Technology and medication errors: impact in nursing homes
    Baril, Chantal
    Gascon, Viviane
    St-Pierre, Liette
    Lagace, Denis
    INTERNATIONAL JOURNAL OF HEALTH CARE QUALITY ASSURANCE, 2014, 27 (03) : 244 - +
  • [29] Report criticises antipsychotic use in US nursing homes
    Devi, Sharmila
    LANCET, 2011, 378 (9786): : 116 - 116
  • [30] Antipsychotic Use in Nursing Homes Varies by Psychiatric Consultant
    Tjia, Jennifer
    Field, Terry
    Lemay, Celeste
    Mazor, Kathleen
    Pandolfi, Michelle
    Spenard, Ann
    Ho, Shih-Yieh
    Kanaan, Abir
    Donovan, Jennifer
    Gurwitz, Jerry H.
    Briesacher, Becky
    MEDICAL CARE, 2014, 52 (03) : 267 - 271